115 related articles for article (PubMed ID: 8391305)
21. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
Wilkoff LJ; Dulmadge EA
J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
[TBL] [Abstract][Full Text] [Related]
22. Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms.
Saito T; Hikita M; Kohno K; Sato S; Takano H; Kobayashi M
Cancer; 1992 Nov; 70(10):2402-9. PubMed ID: 1358426
[TBL] [Abstract][Full Text] [Related]
23. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
Twentyman PR; Fox NE; Wright KA; Bleehen NM
Br J Cancer; 1986 Apr; 53(4):529-37. PubMed ID: 3011054
[TBL] [Abstract][Full Text] [Related]
24. Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil.
Twentyman PR; Fox NE; Bleehen NM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1355-8. PubMed ID: 3019960
[TBL] [Abstract][Full Text] [Related]
25. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle.
Locke V; Davey R; Davey M
Cytometry; 2001 Mar; 43(3):170-4. PubMed ID: 11170102
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Mirski SE; Gerlach JH; Cole SP
Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of growth inhibition due to vincristine by ascorbic acid in a resistant human non-small cell lung cancer cell line.
Song EJ; Yang VC; Chiang CD; Chao CC
Eur J Pharmacol; 1995 Jan; 292(2):119-25. PubMed ID: 7720783
[TBL] [Abstract][Full Text] [Related]
29. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
Heike Y; Takahashi M; Ohira T; Arioka H; Funayama Y; Nishio K; Ogasawara H; Saijo N
Cancer Chemother Pharmacol; 1995; 35(3):200-4. PubMed ID: 7805177
[TBL] [Abstract][Full Text] [Related]
30. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
Coley HM; Twentyman PR; Workman P
Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
[TBL] [Abstract][Full Text] [Related]
31. Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localization.
Wessel I; Jensen PB; Falck J; Mirski SE; Cole SP; Sehested M
Cancer Res; 1997 Oct; 57(20):4451-4. PubMed ID: 9377550
[TBL] [Abstract][Full Text] [Related]
32. Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells.
Nishio K; Nakamura T; Koh Y; Kanzawa F; Tamura T; Saijo N
Cancer; 2001 Apr; 91(8):1494-9. PubMed ID: 11301397
[TBL] [Abstract][Full Text] [Related]
33. [Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice].
Fujita F; Fujita M; Fujita M; Sakamoto Y
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2749-55. PubMed ID: 7993110
[TBL] [Abstract][Full Text] [Related]
34. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
[TBL] [Abstract][Full Text] [Related]
35. Human tumor cells resistant to verapamil.
Huber KR; Schmidt WF; al-Assaad B; Neuberg RW; Ettinger RS
Biochem Biophys Res Commun; 1989 Jun; 161(3):1312-8. PubMed ID: 2742589
[TBL] [Abstract][Full Text] [Related]
36. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
McClean S; Hosking LK; Hill BT
J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
[TBL] [Abstract][Full Text] [Related]
37. [Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine].
Saito Y; Mori K; Tominaga K; Yokoi K; Miyazawa N
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2129-32. PubMed ID: 1653559
[TBL] [Abstract][Full Text] [Related]
38. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T; Brisgand D; Pujol JL; Douillard JY; Monnier A; Rivière A; Chomy P; Le Groumellec A; Ruffie P; Gottfried M; Gaspard MH; Chevreau C; Alberola V; Cigolari S; Besson F; Martinez A; Besenval M; Berthaud P; Tursz T
Bull Cancer; 1996 May; 83(5):385-94. PubMed ID: 8680091
[TBL] [Abstract][Full Text] [Related]
39. Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.
Reeve JG; Rabbitts PH; Twentyman PR
Br J Cancer; 1989 Sep; 60(3):339-42. PubMed ID: 2571355
[TBL] [Abstract][Full Text] [Related]
40. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
